138 related articles for article (PubMed ID: 35015835)
1. Systems medicine dissection of chr1q-amp reveals a novel PBX1-FOXM1 axis for targeted therapy in multiple myeloma.
Trasanidis N; Katsarou A; Ponnusamy K; Shen YA; Kostopoulos IV; Bergonia B; Keren K; Reema P; Xiao X; Szydlo RM; Sabbattini PMR; Roberts IAG; Auner HW; Naresh KN; Chaidos A; Wang TL; Magnani L; Caputo VS; Karadimitris A
Blood; 2022 Mar; 139(13):1939-1953. PubMed ID: 35015835
[TBL] [Abstract][Full Text] [Related]
2. Induction of Chromosome Instability by Activation of Yes-Associated Protein and Forkhead Box M1 in Liver Cancer.
Weiler SME; Pinna F; Wolf T; Lutz T; Geldiyev A; Sticht C; Knaub M; Thomann S; Bissinger M; Wan S; Rössler S; Becker D; Gretz N; Lang H; Bergmann F; Ustiyan V; Kalin TV; Singer S; Lee JS; Marquardt JU; Schirmacher P; Kalinichenko VV; Breuhahn K
Gastroenterology; 2017 Jun; 152(8):2037-2051.e22. PubMed ID: 28249813
[TBL] [Abstract][Full Text] [Related]
3. FOXM1 regulates glycolysis and energy production in multiple myeloma.
Cheng Y; Sun F; Thornton K; Jing X; Dong J; Yun G; Pisano M; Zhan F; Kim SH; Katzenellenbogen JA; Katzenellenbogen BS; Hari P; Janz S
Oncogene; 2022 Aug; 41(32):3899-3911. PubMed ID: 35794249
[TBL] [Abstract][Full Text] [Related]
4. Exosomal lncRNA NEAT1 Inhibits NK-Cell Activity to Promote Multiple Myeloma Cell Immune Escape via an EZH2/PBX1 Axis.
Wang QM; Lian GY; Sheng SM; Xu J; Ye LL; Min C; Guo SF
Mol Cancer Res; 2024 Feb; 22(2):125-136. PubMed ID: 37889101
[TBL] [Abstract][Full Text] [Related]
5. Oligomeric self-association contributes to E2A-PBX1-mediated oncogenesis.
Lin CH; Wang Z; Duque-Afonso J; Wong SH; Demeter J; Loktev AV; Somervaille TCP; Jackson PK; Cleary ML
Sci Rep; 2019 Mar; 9(1):4915. PubMed ID: 30894657
[TBL] [Abstract][Full Text] [Related]
6. PBX1 as a novel master regulator in cancer: Its regulation, molecular biology, and therapeutic applications.
Kao TW; Chen HH; Lin J; Wang TL; Shen YA
Biochim Biophys Acta Rev Cancer; 2024 Mar; 1879(2):189085. PubMed ID: 38341110
[TBL] [Abstract][Full Text] [Related]
7. Identification of FOXM1 as a specific marker for triple‑negative breast cancer.
Tan Y; Wang Q; Xie Y; Qiao X; Zhang S; Wang Y; Yang Y; Zhang B
Int J Oncol; 2019 Jan; 54(1):87-97. PubMed ID: 30365046
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive clinicopathological significance and putative transcriptional mechanisms of Forkhead box M1 factor in hepatocellular carcinoma.
Wu HY; Luo LF; Wei F; Jiang HM
World J Surg Oncol; 2023 Nov; 21(1):366. PubMed ID: 38001498
[TBL] [Abstract][Full Text] [Related]
9. The pioneer factor PBX1 is a novel driver of metastatic progression in ERα-positive breast cancer.
Magnani L; Patten DK; Nguyen VT; Hong SP; Steel JH; Patel N; Lombardo Y; Faronato M; Gomes AR; Woodley L; Page K; Guttery D; Primrose L; Fernandez Garcia D; Shaw J; Viola P; Green A; Nolan C; Ellis IO; Rakha EA; Shousha S; Lam EW; Győrffy B; Lupien M; Coombes RC
Oncotarget; 2015 Sep; 6(26):21878-91. PubMed ID: 26215677
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of FOXM1 expression and antitumor effect of FOXM1 inhibition in synovial sarcomas.
Maekawa A; Kohashi K; Kuda M; Iura K; Ishii T; Endo M; Nakatsura T; Iwamoto Y; Oda Y
BMC Cancer; 2016 Jul; 16():511. PubMed ID: 27439614
[TBL] [Abstract][Full Text] [Related]
11. Thiostrepton selectively targets breast cancer cells through inhibition of forkhead box M1 expression.
Kwok JM; Myatt SS; Marson CM; Coombes RC; Constantinidou D; Lam EW
Mol Cancer Ther; 2008 Jul; 7(7):2022-32. PubMed ID: 18645012
[TBL] [Abstract][Full Text] [Related]
12. Involvement of Transcriptional Factor Pbx1 in Peripheral B Cell Homeostasis to Constrain Lupus Autoimmunity.
Gu S; Zhang J; Han X; Ding H; Yao C; Ye Z; Yin Z; Hou G; Jiang Y; Qian J; Zhou H; Guo Q; Chen S; Dai D; Shen N
Arthritis Rheumatol; 2023 Aug; 75(8):1381-1394. PubMed ID: 36862399
[TBL] [Abstract][Full Text] [Related]
13. Hyper-activation of Aurora kinase a-polo-like kinase 1-FOXM1 axis promotes chronic myeloid leukemia resistance to tyrosine kinase inhibitors.
Mancini M; De Santis S; Monaldi C; Bavaro L; Martelli M; Castagnetti F; Gugliotta G; Rosti G; Santucci MA; Martinelli G; Cavo M; Soverini S
J Exp Clin Cancer Res; 2019 May; 38(1):216. PubMed ID: 31122263
[TBL] [Abstract][Full Text] [Related]
14. The forkhead box M1 (FOXM1) expression and antitumor effect of FOXM1 inhibition in malignant rhabdoid tumor.
Shibui Y; Kohashi K; Tamaki A; Kinoshita I; Yamada Y; Yamamoto H; Taguchi T; Oda Y
J Cancer Res Clin Oncol; 2021 May; 147(5):1499-1518. PubMed ID: 33221995
[TBL] [Abstract][Full Text] [Related]
15. 1q amplification and PHF19 expressing high-risk cells are associated with relapsed/refractory multiple myeloma.
Johnson TS; Sudha P; Liu E; Becker N; Robertson S; Blaney P; Morgan G; Chopra VS; Dos Santos C; Nixon M; Huang K; Suvannasankha A; Zaid MA; Abonour R; Walker BA
Nat Commun; 2024 May; 15(1):4144. PubMed ID: 38755140
[TBL] [Abstract][Full Text] [Related]
16. Multi-omics analysis reveals epithelial-mesenchymal transition-related gene FOXM1 as a novel prognostic biomarker in clear cell renal carcinoma.
Song J; Song F; Liu K; Zhang W; Luo R; Tang Y; Ran L
Aging (Albany NY); 2019 Nov; 11(22):10316-10337. PubMed ID: 31743108
[TBL] [Abstract][Full Text] [Related]
17. Thiostrepton inhibits growth and induces apoptosis by targeting FoxM1/SKP2/MTH1 axis in B-precursor acute lymphoblastic leukemia cells.
Kuttikrishnan S; Prabhu KS; Khan AQ; Alali FQ; Ahmad A; Uddin S
Leuk Lymphoma; 2021 Dec; 62(13):3170-3180. PubMed ID: 34369229
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanism of Forkhead box M1 inhibition by thiostrepton in breast cancer cells.
Kongsema M; Wongkhieo S; Khongkow M; Lam EW; Boonnoy P; Vongsangnak W; Wong-Ekkabut J
Oncol Rep; 2019 Sep; 42(3):953-962. PubMed ID: 31322278
[TBL] [Abstract][Full Text] [Related]
19. c-FLIP promotes drug resistance in non-small-cell lung cancer cells via upregulating FoxM1 expression.
Wang WD; Shang Y; Wang C; Ni J; Wang AM; Li GJ; Su L; Chen SZ
Acta Pharmacol Sin; 2022 Nov; 43(11):2956-2966. PubMed ID: 35422085
[TBL] [Abstract][Full Text] [Related]
20. MCL1 gene co-expression module stratifies multiple myeloma and predicts response to proteasome inhibitor-based therapy.
Samo AA; Li J; Zhou M; Sun Y; Yang Y; Zhang Y; Li J; van Duin M; Lu X; Fan X
Genes Chromosomes Cancer; 2018 Aug; 57(8):420-429. PubMed ID: 29696703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
